Home trading
 

Keywords :   


Tag: trading

Bloodletting 8 Trading Days In A Row: Junk Bonds Go To Heck

2015-11-17 00:58:56| Automakers - Topix.net

The US junk bond market, after years of record-breaking issuance, has nearly doubled to $1.8 trillion since late 2008, one of the miracles the Fed's QE and ZIRP performed. Those were the good times.

Tags: to days trading row

 

TransDigm Group Sees Unusually-High Trading Volume After Analyst Upgrade

2015-11-16 22:53:22| Logistics - Topix.net

Shares of TransDigm Group saw an uptick in trading volume on Monday after Deutsche Bank raised their price target on the stock from $223.00 to $235.00, Marketbeat.com reports. 807,969 shares changed hands during mid-day trading, an increase of 64% from the previous session's volume of 491,614 shares.The stock last traded at $231.52 and had previously closed at $229.72.

Tags: group volume trading upgrade

 
 

United States Steel Bonds Drop 4.1% During Trading Analyst

2015-11-14 00:56:48| Steel - Topix.net

An issue of United States Steel bonds fell 4.1% as a percentage of their face value during trading on Friday after Barclays lowered their price target on the stock from $15.00 to $14.00, MarketBeat reports. The high-yield debt issue has a 7.375% coupon and will mature on April 1, 2020.

Tags: united states united states drop

 

TransDigm Group Trading 5.2% Higher Following Better-Than-Expected Earnings

2015-11-12 23:04:25| Logistics - Topix.net

Shares of TransDigm Group traded up 5.2% on Thursday following a stronger than expected earnings report, Analyst Ratings Network.com reports. The stock traded as high as $234.48 and last traded at $230.20, with a volume of 638,531 shares.

Tags: group higher trading earnings

 

Valeant, Ackman must face U.S. insider trading lawsuit

2015-11-12 01:40:19| Biotech - Topix.net

A U.S. judge said Valeant Pharmaceuticals International Inc. and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before making an unsuccessful takeover bid for the maker of Botox. In a Nov. 9 decision, U.S. District Judge David Carter in Santa Ana, California, rejected arguments by Valeant, Ackman and Ackman's Pershing Square Capital Management that the lawsuit should be dismissed because their activity was not fraudulent.

Tags: face trading insider lawsuit

 

Sites : [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] next »